Clominorex
Appearance
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Vanished user 0x8cSXE0x6 (talk | contribs) at 22:54, 28 August 2014. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 22:54, 28 August 2014 by Vanished user 0x8cSXE0x6 (talk | contribs)
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C9H9ClN2O |
Molar mass | 196.63 g/mol g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Clominorex is a centrally acting sympathomimetic which is related to other drugs such as aminorex and pemoline. It was developed as an appetite suppressant by McNeil Laboratories in the 1950s.[1]
See also
References
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Clominorex" – news · newspapers · books · scholar · JSTOR (September 2009) (Learn how and when to remove this message) |
- ^ US Patent 3278382 - 2-amino-5-aryloxazoline compositions and methods of using same
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Infobox drug articles with non-default infobox title
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Articles needing additional references from September 2009
- All articles needing additional references
- All stub articles